1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > In Vitro Diagnostics

In-Vitro Testing Equipment Industry: Comprehensive Market Analysis

  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
0 vote

In Vitro Diagnostics

The process of testing and analyzing human samples, such as blood or tissue to diagnose infections and health conditions is called in vitro diagnostics (IVDs). The purpose of IVD tests is to assess the health status of a patient. These tests are performed outside of the body. Checking blood for signs of infections, tests for infectious disease, such as HIV or hepatitis, cholesterol, anaemia and for various genetic diseases or conditions are common uses of IVDs.

Federal agencies involved in the regulation of IVDs in the USA include the Food and Drug Administration and the Centers for Medicare & Medicaid Services. Roche Diagnostics Limited, Abbott Laboratories, Inc. and Siemens Healthcare are some of the major players in the in vitro market.

Key Market Segments

IVDs of the types mentioned below are used in health care in numerous ways and at various points.

Clinical laboratory testing: These tests are generally prescribed by the physician. The information obtained assists in the evaluation of overall health, in disease diagnosis and in the establishment of appropriate treatment. Clinical laboratory tests influence approximately 70% of healthcare decisions.

Point-of-care diagnostics: This kind of test is carried out by healthcare professionals, such as doctors, nurses or paramedics. These tests do not require specialist laboratory facilities and can normally deliver results very quickly. This type of testing is used for providing insights for a preliminary diagnosis or for managing patient conditions.

Self-testing: These tests are designed for patients or individuals to use themselves. They do not require any specialist facilities, and the user can usually interpret the information. The most familiar are bloodsugar tests for managing diabetes and home pregnancy tests, but a variety of other tests is becoming widely available. HIV self-testing is increasingly being sought and offered globally.

Regional Market Shares

Increasing emphasis on the early detection of diseases and infections is likely to drive the global demand for IVDs to about $75 billion by 2020. The USA, Europe and Asia account for the largest share of the IVD market.

The USA is one of the largest markets for IVDs in the world, with a market value of more than $24 billion. Professional point-of-care diagnostics is the largest segment in the USA. Population aging and expansion of the insured population resulting from the Affordable Care Act are likely to drive growth of the US IVD market to more than $28 billion in the near future.

The healthcare system in most of Europe depends on government funding. As a result the IVD market in Europe has recently witnessed slow growth as governments have cut costs. Increasing incidence of serious diseases has, however, driven up the market; the European market for cancer IVD, for instance, was worth more than $1.5 billion in 2015.

Asia’s IVD market is estimated to be worth more than $17 billion. Corporate firms offering annual health checks for their employees and insurance companies conducting pre-insurance policy checks are fuelling the industry. Increasing levels of chronic diseases, patient awareness, patient self testing and significant urban populations are driving the uptake of various IVD tests and creating opportunities for market expansion.

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 600 reports

Global In Vitro Diagnostic Reagent Industry

  • May 2016
    20 pages
  • In Vitro Diagno...  

    Digestive Syste...  

  • United States  

    Africa  

    World  

View report >

In Vitro Diagnostics Industry in the US

  • January 2016
    11 pages
  • United States  

View report >

In Vitro Diagnostic Reagent Industry in Europe

  • January 2015
    6 pages
  • In Vitro Diagno...  

    Clinical Diagno...  

  • Europe  

View report >

In Vitro Diagnostics Markets in Japan

  • November 2015
    12 pages
  • Japan  

    United States  

View report >

In Vitro Diagnostic Reagent Industry in France

  • June 2016
    17 pages
  • In Vitro Diagno...  

  • France  

    Europe  

    Brazil  

View report >

In Vitro Diagnostics Markets in Germany

  • March 2016
    16 pages
  • In Vitro Diagno...  

    In Vitro Diagno...  

  • Germany  

    United States  

View report >

In Vitro Diagnostics Industry in Italy

  • January 2014
    9 pages
  • Cervical Cancer  

  • Italy  

View report >

In Vitro Diagnostic Reagent Statistics in the UK

  • April 2016
    5 pages
  • In Vitro Diagno...  

  • United Kingdom  

View report >

In Vitro Diagnostics Industry in Brazil

  • March 2016
    7 pages
  • Pap Smear  

    In Vitro Diagno...  

    Pap Test  

  • Brazil  

View report >

Search in In Vitro Diagnostics Industry (About 600 reports)
Parent industry: Medical Device
Related industries: Diagnostic Imaging, Cardiovascular Devices, Orthopedics, Respiratory Device, Surgical Equipment, Dialysis Device, Endoscopic Device, Patient Monitoring Device

About 6 100 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 199 - $ 28 500)

2016-2020 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2016-2020 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28 500
  • Industry report
  • May 2016
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

Competing In The 2016-2020 Global Clinical Chemistry An ...

May 2016 $ 21 800

Global Coagulation Market New Frontiers, Business Chal ...

July 2016 $ 21 100

Hemostasis Diagnostics Market: Global Opportunities And ...

July 2016 $ 21 100

Hemostasis Analyzers And Consumables: Us, Europe, Japan ...

June 2016 $ 21 100

Competing In The 2016-2020 Global Infectious Disease Te ...

May 2016 $ 21 100

Competing In The 2016-2020 Global Coagulation Testing M ...

May 2016 $ 21 100

Hemostasis Diagnostics 2016-2020: Supplier Shares, Coun ...

May 2016 $ 21 100

Competing In The 2016-2020 Global Hematology And Flow C ...

May 2016 $ 21 100

Coagulation Testing 2016-2020: Instrument And Reagents ...

May 2016 $ 21 100

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.